Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Prostate Cancer
100%
Hormone Refractory
100%
Nuclear Accumulation
100%
Androgen Sensitivity
100%
Histone Deacetylase 4 (HDAC4)
100%
Refractory Cancer
100%
Androgens
28%
Androgen-independent
28%
CWR22
28%
Cancer Cells
14%
Inhibitory Effect
14%
Prostate
14%
Aggressive Phenotype
14%
Androgen Independence
14%
Putative Drug Targets
14%
LNCaP
14%
Benign Prostatic Hyperplasia
14%
Benign Tissue
14%
LNCaP Cells
14%
Immunohistochemical Staining
14%
Nuclear Localization
14%
Responsive Systems
14%
Primary Refractory
14%
Histone Deacetylase Activity
14%
Androgen Responsiveness
14%
Androgen Treatment
14%
Quantitative Immunohistochemistry
14%
Immunofluorescence Staining
14%
Enzymatic Function
14%
Mouse Xenograft Model
14%
Medicine and Dentistry
Malignant Neoplasm
100%
Androgen
100%
Histone Deacetylase 4
100%
Prostate Cancer
28%
Cancer Cell
14%
Diseases
14%
Xenograft
14%
Prostate Hypertrophy
14%
Immunofluorescence
14%
Enzyme Activity
14%
Histone Deacetylase
14%
Androgen Therapy
14%
Therapeutic Target
14%
Biochemistry, Genetics and Molecular Biology
Histone Deacetylase
100%
LNCaP
25%
Staining
25%
Cancer Cell
12%
Immunofluorescence
12%
Enzyme Activity
12%